These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 24462433

  • 1. Self-reported histories of disease and vaccination against measles, mumps, rubella and varicella in health care personnel in Japan.
    Kumakura S, Onoda K, Hirose M.
    J Infect Chemother; 2014 Mar; 20(3):194-8. PubMed ID: 24462433
    [Abstract] [Full Text] [Related]

  • 2. Immunity against infectious diseases: predictive value of self-reported history of vaccination and disease.
    Trevisan A, Frasson C, Morandin M, Beggio M, Bruno A, Davanzo E, Di Marco L, Simioni L, Amato G.
    Infect Control Hosp Epidemiol; 2007 May; 28(5):564-9. PubMed ID: 17464916
    [Abstract] [Full Text] [Related]

  • 3. Prevaccination antibody screening and immunization program for healthcare personnel against measles, mumps, rubella, and varicella in a Japanese tertiary care hospital.
    Kanamori H, Tokuda K, Ikeda S, Endo S, Ishizawa C, Hirai Y, Takahashi M, Aoyagi T, Hatta M, Gu Y, Yano H, Weber DJ, Kaku M.
    Tohoku J Exp Med; 2014 Oct; 234(2):111-6. PubMed ID: 25224029
    [Abstract] [Full Text] [Related]

  • 4. [Seroprevalence of measles, rubella, mumps and varicella in health workers in the Community of Madrid].
    Rodríguez ML, Martínez D, Santos-Sancho JM, Borda JR, Orero A.
    Rev Esp Quimioter; 2014 Jun; 27(2):98-101. PubMed ID: 24940889
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan.
    Hatakeyama S, Moriya K, Itoyama S, Nukui Y, Uchida M, Shintani Y, Morisawa Y, Kimura S.
    Infect Control Hosp Epidemiol; 2004 Jul; 25(7):591-4. PubMed ID: 15301032
    [Abstract] [Full Text] [Related]

  • 6. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?
    Celikbas A, Ergonul O, Aksaray S, Tuygun N, Esener H, Tanir G, Eren S, Baykam N, Guvener E, Dokuzoguz B.
    Am J Infect Control; 2006 Nov; 34(9):583-7. PubMed ID: 17097453
    [Abstract] [Full Text] [Related]

  • 7. [Antibody titers against measles, rubella, mumps and varicella-zoster viruses in medical students].
    Yoshida N, Tsumura N, Toyomasu K, Sagawa K.
    Sangyo Eiseigaku Zasshi; 2007 Jan; 49(1):21-6. PubMed ID: 17303935
    [Abstract] [Full Text] [Related]

  • 8. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save?
    Alp E, Cevahir F, Gökahmetoglu S, Demiraslan H, Doganay M.
    J Infect Public Health; 2012 Apr; 5(2):127-32. PubMed ID: 22541258
    [Abstract] [Full Text] [Related]

  • 9. Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan.
    Asari S, Deguchi M, Tahara K, Taniike M, Toyokawa M, Nishi I, Watanabe M, Iwatani Y, Makimoto K.
    Am J Infect Control; 2003 May; 31(3):157-62. PubMed ID: 12734521
    [Abstract] [Full Text] [Related]

  • 10. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ, Consistency Lot Study Group for ProQuad.
    Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
    [Abstract] [Full Text] [Related]

  • 11. Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy.
    Kumakura S, Shibata H, Onoda K, Nishimura N, Matsuda C, Hirose M.
    Epidemiol Infect; 2014 Jan; 142(1):12-9. PubMed ID: 23574767
    [Abstract] [Full Text] [Related]

  • 12. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
    Shinefield HR, Black S, Kuter BJ.
    J Infect Dis; 2008 Mar 01; 197 Suppl 2():S152-5. PubMed ID: 18419390
    [Abstract] [Full Text] [Related]

  • 13. Influences on immunization rates: Vaccination coverage of mumps, measles, rubella and varicella before and after the STIKO intervention 2011 - A retrospective study.
    Sanftenberg L, Schrörs HJ, Schelling J.
    Vaccine; 2016 Jul 25; 34(34):3938-41. PubMed ID: 27318420
    [Abstract] [Full Text] [Related]

  • 14. Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011.
    Taddei C, Ceccherini V, Niccolai G, Porchia BR, Boccalini S, Levi M, Tiscione E, Santini MG, Baretti S, Bonanni P, Bechini A.
    Hum Vaccin Immunother; 2014 Jul 25; 10(9):2612-22. PubMed ID: 25483489
    [Abstract] [Full Text] [Related]

  • 15. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH, Saracen CL, Peter G.
    Pediatrics; 1994 Oct 25; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [Abstract] [Full Text] [Related]

  • 16. Seroprevalence of measles, mumps, rubella and varicella among staff of a hospital in Riyadh, Saudi Arabia.
    Abbas M, Atwa M, Emara A.
    J Egypt Public Health Assoc; 2007 Oct 25; 82(3-4):283-97. PubMed ID: 18410713
    [Abstract] [Full Text] [Related]

  • 17. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T, Bernstein DI, Block SL, Hilty M, Keyserling HL, Marchant C, Marshall H, Richmond P, Yogev R, Cordova J, Cho I, Mendelman PM, LAIV Study Group.
    Pediatrics; 2008 Mar 25; 121(3):508-16. PubMed ID: 18310199
    [Abstract] [Full Text] [Related]

  • 18. [Combined vaccine against measles, mumps, rubella and varicella and recommendations for varicella immunization in Italy?].
    Papa R, Spinelli R, Zaratti L, Franco E.
    Ig Sanita Pubbl; 2007 Mar 25; 63(6):715-22. PubMed ID: 18216886
    [Abstract] [Full Text] [Related]

  • 19. [Measles, mumps, rubella and varicella: antibody titration and vaccinations in a large hospital].
    Cologni L, Belotti L, Bacis M, Moioli F, Goglio A, Mosconi G.
    G Ital Med Lav Ergon; 2012 Mar 25; 34(3 Suppl):272-4. PubMed ID: 23405639
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
    Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, Soemantri P, Walther U, Macholdt U, Douha M, Pierson P, Willems P.
    Pediatr Infect Dis J; 2008 Aug 25; 27(8):724-30. PubMed ID: 18600190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.